Clockwise from top left, Jennifer B. Green, MD, Carolyn S.P. Lam, MBBS, PhD, Otávio Berwanger, MD, PhD, Subodh Verma, MD, PhD, FRCSC, and Mikhail N. Kosiborod, MD, discuss questions from Scientific Sessions attendees following a symposium on DARE-19 trial results. The session’s presentations and the Q&A discussion can be viewed on-demand.
Q&A: Efficacy and Safety of Dapagliflozin in Patients with and without Type 2 Diabetes Hospitalized with COVID-19— Results from the DARE-19 Global Randomized Controlled Trial
